This post is by Iris Dorbian from PE Hub Blog: Venture Capital Deals
Click here to view on the original site: Original Post
Durham, North Carolina-based StrideBio Inc, a developer of novel AAV vectors for in vivo gene therapies, has raised $15.7 million in Series A funding. Hatteras Venture Partners led the round with participation from other investors that included Takeda Ventures Inc, UCB Ventures and Alexandria Venture Investments LLC. In addition to the funding, Dr. Jayson Punwani, a partner at Takeda Ventures Inc. and Dr. Erica Whittaker, vice president and head of UCB Ventures, have joined StrideBio’s board of directors.
Source: Press Release